Indirect CD4+ T-cell-mediated elimination of MHC IINEG tumor cells is spatially restricted and fails to prevent escape of antigen-negative cells

被引:15
|
作者
Tveita, Anders A. [1 ,2 ]
Schjesvold, Fredrik H. [1 ,2 ]
Sundnes, Olav [2 ,3 ,4 ]
Haabeth, Ole Audun W. [1 ,2 ]
Haraldsen, Guttorm [2 ,3 ,4 ]
Bogen, Bjarne [1 ,2 ,5 ]
机构
[1] Univ Oslo, Inst Immunol, Ctr Immune Regulat, N-0027 Oslo, Norway
[2] Oslo Univ Hosp, Oslo, Norway
[3] Univ Oslo, Dept Pathol, N-0027 Oslo, Norway
[4] Univ Oslo, KG Jebsen Inflammat Res Ctr, N-0027 Oslo, Norway
[5] Univ Oslo, KG Jebsen Ctr Res Influenza Vaccines, Inst Immunol, N-0027 Oslo, Norway
关键词
Bystander killing; CD4(+) T-cell immunotherapy; Macrophage cytotoxicity; Macrophage polarization; Myeloma; COMPLEX CLASS-II; LARGE ESTABLISHED MELANOMA; B-LYMPHOMA CELLS; IFN-GAMMA; IN-VIVO; DENDRITIC CELLS; TH1; CELLS; MACROPHAGES; CANCER; IDIOTYPE;
D O I
10.1002/eji.201444659
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor-specific Th1 cells can activate tumor-infiltrating macrophages that eliminateMHC class II negative (MHC IINEG) tumor cells. Activated M1-like macrophages lack antigen (Ag) receptors, and are presumably unable to discriminate and thus kill both Ag-positive (Ag-POS) and Ag-negative (Ag-NEG) tumor cells (bystander killing). The lack of specificity of macrophage-mediated cytotoxicity might be of clinical importance as it could provide a means of avoiding tumor escape. Here, we have tested this idea using mixed populations of Ag-POS and Ag-NEG tumor cells in a TCR-transgenic model in which CD4(+) T cells recognize a secreted tumor-specific antigen. Surprisingly, while Ag-POS tumor cells were recognized and rejected, Ag-NEG cells grew unimpeded and formed tumors. We further demonstrated that macrophage-mediated cytotoxicity was spatially restricted to areas dominated by Ag-POS tumor cells, sparing Ag-NEG tumor cells in the vicinity. As a consequence, macrophage tumoricidal activity did not confer bystander killing in vivo. The present results offer novel insight into the mechanisms of indirect Th1-mediated elimination of MHC IINEG tumor cells.
引用
收藏
页码:2625 / 2637
页数:13
相关论文
共 50 条
  • [1] CD4+ T-cell-Mediated Rejection of MHC Class II-Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
    Haabeth, Ole Audun W.
    Fauskanger, Marte
    Manzke, Melanie
    Lundin, Katrin U.
    Corthay, Alexandre
    Bogen, Bjarne
    Tveita, Anders A.
    [J]. CANCER RESEARCH, 2018, 78 (16) : 4573 - 4585
  • [2] Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell-Mediated Antitumor Immunity
    Brentville, Victoria A.
    Metheringham, Rachael L.
    Gunn, Barbara
    Symonds, Peter
    Daniels, Ian
    Gijon, Mohamed
    Cook, Katherine
    Xue, Wei
    Durrant, Lindy G.
    [J]. CANCER RESEARCH, 2016, 76 (03) : 548 - 560
  • [3] Acquisition of MHC:peptide complexes by mouse CD4+ T cells may play a role in T-cell-mediated immunoregulation
    Tsang, JYS
    Chai, JG
    Lechler, R
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (07) : 2849 - 2850
  • [5] CD4+ T-CELL-MEDIATED KILLING OF MHC CLASS-II-POSITIVE ANTIGEN-PRESENTING CELLS .1. CHARACTERIZATION OF TARGET-CELL RECOGNITION BY INVIVO OR INVITRO ACTIVATED CD4+ KILLER T-CELLS
    ERB, P
    GROGG, D
    TROXLER, M
    KENNEDY, M
    FLURI, M
    [J]. JOURNAL OF IMMUNOLOGY, 1990, 144 (03): : 790 - 795
  • [6] FAS ANTIGEN IS THE MAJOR TARGET MOLECULE FOR CD4+ T-CELL-MEDIATED CYTOTOXICITY
    STALDER, T
    HAHN, SH
    ERB, P
    [J]. JOURNAL OF IMMUNOLOGY, 1994, 152 (03): : 1127 - 1133
  • [7] Suppression of T cell activation by CD4+, CD25+ regulatory T cells is MHC class II restricted
    Germana, Sharon
    LeGuern, Christian
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 : S217 - S217
  • [8] CD8+ T-cell Responses Rapidly Select for Antigen-Negative Tumor Cells in the Prostate
    Bak, S. Peter
    Barnkob, Mike Stein
    Wittrup, K. Dane
    Chen, Jianzhu
    [J]. CANCER IMMUNOLOGY RESEARCH, 2013, 1 (06) : 393 - 401
  • [9] The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity
    Wang, RF
    [J]. TRENDS IN IMMUNOLOGY, 2001, 22 (05) : 269 - 276
  • [10] CD4+ T cells cross-compete for MHC class II-restricted peptide antigen complexes on the surface of antigen presenting cells
    Hayball, JD
    Robinson, BWS
    Lake, RA
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2004, 82 (02): : 103 - 111